These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 17030849)
1. The CR4 region of EBNA2 confers viability of Epstein-Barr virus-transformed B cells by CBF1-independent signalling. Grabusic K; Maier S; Hartmann A; Mantik A; Hammerschmidt W; Kempkes B J Gen Virol; 2006 Nov; 87(Pt 11):3169-3176. PubMed ID: 17030849 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites. Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide. Farrell CJ; Lee JM; Shin EC; Cebrat M; Cole PA; Hayward SD Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4625-30. PubMed ID: 15070768 [TBL] [Abstract][Full Text] [Related]
4. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus. Pich D; Mrozek-Gorska P; Bouvet M; Sugimoto A; Akidil E; Grundhoff A; Hamperl S; Ling PD; Hammerschmidt W mBio; 2019 Sep; 10(5):. PubMed ID: 31530670 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway. Pegman PM; Smith SM; D'Souza BN; Loughran ST; Maier S; Kempkes B; Cahill PA; Simmons MJ; Gélinas C; Walls D J Virol; 2006 Aug; 80(16):8133-44. PubMed ID: 16873269 [TBL] [Abstract][Full Text] [Related]
6. Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines. Yoo L; Speck SH J Virol; 2000 Dec; 74(23):11115-20. PubMed ID: 11070007 [TBL] [Abstract][Full Text] [Related]
7. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Zimber-Strobl U; Strobl LJ Semin Cancer Biol; 2001 Dec; 11(6):423-34. PubMed ID: 11669604 [TBL] [Abstract][Full Text] [Related]
8. The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenance. Gordadze AV; Poston D; Ling PD J Virol; 2002 Jul; 76(14):7349-55. PubMed ID: 12072534 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Zhao B; Zou J; Wang H; Johannsen E; Peng CW; Quackenbush J; Mar JC; Morton CC; Freedman ML; Blacklow SC; Aster JC; Bernstein BE; Kieff E Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14902-7. PubMed ID: 21746931 [TBL] [Abstract][Full Text] [Related]
10. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation. Harada S; Yalamanchili R; Kieff E J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732 [TBL] [Abstract][Full Text] [Related]
11. EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance. Gordadze AV; Onunwor CW; Peng R; Poston D; Kremmer E; Ling PD J Virol; 2004 Apr; 78(8):3919-29. PubMed ID: 15047808 [TBL] [Abstract][Full Text] [Related]
12. B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1. Yoo LI; Mooney M; Puglielli MT; Speck SH J Virol; 1997 Dec; 71(12):9134-42. PubMed ID: 9371570 [TBL] [Abstract][Full Text] [Related]
13. LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells. Zhang J; Sommermann T; Li X; Gieselmann L; de la Rosa K; Stecklum M; Klein F; Kocks C; Rajewsky K Front Immunol; 2023; 14():1331730. PubMed ID: 38169736 [TBL] [Abstract][Full Text] [Related]
14. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV. Schlee M; Krug T; Gires O; Zeidler R; Hammerschmidt W; Mailhammer R; Laux G; Sauer G; Lovric J; Bornkamm GW J Virol; 2004 Apr; 78(8):3941-52. PubMed ID: 15047810 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation. Fuentes-Pananá EM; Ling PD J Virol; 1998 Jan; 72(1):693-700. PubMed ID: 9420275 [TBL] [Abstract][Full Text] [Related]
16. Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus. Gordadze AV; Peng R; Tan J; Liu G; Sutton R; Kempkes B; Bornkamm GW; Ling PD J Virol; 2001 Jul; 75(13):5899-912. PubMed ID: 11390591 [TBL] [Abstract][Full Text] [Related]
17. EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding. Portal D; Zhao B; Calderwood MA; Sommermann T; Johannsen E; Kieff E Proc Natl Acad Sci U S A; 2011 May; 108(19):7808-13. PubMed ID: 21518914 [TBL] [Abstract][Full Text] [Related]
18. The Epstein-Barr virus BamHI C promoter is not essential for B cell immortalization in vitro, but it greatly enhances B cell growth transformation. Tierney RJ; Nagra J; Rowe M; Bell AI; Rickinson AB J Virol; 2015 Mar; 89(5):2483-93. PubMed ID: 25540367 [TBL] [Abstract][Full Text] [Related]
19. EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells. Glaser LV; Rieger S; Thumann S; Beer S; Kuklik-Roos C; Martin DE; Maier KC; Harth-Hertle ML; Grüning B; Backofen R; Krebs S; Blum H; Zimmer R; Erhard F; Kempkes B PLoS Pathog; 2017 Oct; 13(10):e1006664. PubMed ID: 28968461 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes. Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]